Compugen Ltd (CGEN) Live Share Price, Invest From India

Compugen Ltd Stock Performance

as on March 24, 2026 at 6:59 am IST

Day's Low
Day's High
$2.07
Day's Price Range
$2.15
$2.09
0.96%
Downside
2.87%
Upside
52 Week's Low
52 Week's High
$1.13
52-Week Price Range
$2.38
$2.09
45.93%
Downside
13.88%
Upside

Compugen Ltd share price movements today

Previous Close: $2.09
Open: $2.13
Volume: 765.5K
Day's Low - High: $2.07 - $2.15
52 Week Low - High: $1.13 - $2.38

Compugen Ltd Historical Returns

1 Month Return: + 22.22 %
3 Month Return: + 37.5 %
1 Year Return: + 33.12 %
3 Year Return: + 193.66 %
5 Year Return: -75.58 %

Compugen Ltd Stock Fundamentals & Key Indicators

Check Compugen Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$198.5M

EPS (TTM)

-0.3267

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

5.5

Industry PE ratio

-4.738881355932204

PEG Ratio

1.2874

EBITDA

31.8M

Revenue (TTM)

72.8M

Profit Margin

48.57%

Return On Equity TTM

44.84%

Compugen Ltd Stock Valuation

Track how Compugen Ltd P/E has moved over time to understand its valuation trends.

Compugen Ltd in the last 5 years

Overview
Trends

Lowest (-28.43x)

March 31, 2021

Industry (-4.74x)

March 23, 2026

Today (5.50x)

March 23, 2026

Highest (75.44x)

September 30, 2024

LowHigh

Today’s Price to Earnings Ratio: 5.50x

Compugen Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Compugen Ltd with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Compugen Ltd	BUY	$198.5M	-75.58%	5.5	48.57%
Alnylam Pharmaceuticals, Inc.	BUY	$41.4B	125.13%	133.41	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$115.3B	112.56%	29.67	32.94%
Beone Medicines Ltd	NA	$31.6B	NA	111	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$77.5B	56.01%	17.67	31.41%

Stock Returns calculator for Compugen Ltd Stock including INR - Dollar returns

The Compugen Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Compugen Ltd investment value today

Current value as on today

₹1,43,040

Returns

₹43,040

(+43.04%)

Returns from Compugen Ltd Stock

₹33,121 (+33.12%)

Dollar Returns*

₹9,919 (+9.92%)

Analyst Recommendation on Compugen Ltd Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Compugen Ltd. Average target price of $5.8

Compugen Ltd Share Price Target

Get share price movements and forecasts by analysts on Compugen Ltd.

What analysts predicted

63.97%UPSIDE

Target Price

$5.8

Current Price

$2.09

Analyzed by

9 Analysts

Target

$5.80

Compugen Ltd target price $5.8, a slight upside of 63.97% compared to current price of $2.09. According to 9 analysts rating.

Compugen Ltd Stock’s Investor Sentiment and Interest

Search interest for Compugen Ltd Stock has increased by 36% in the last 30 days, reflecting an upward trend in search activity.

Time period: February 22, 2026 to March 24, 2026

Change:36% versus previous 30 day period

Compugen Ltd Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	33	2	6	17	1	2	1	1	67
Gross Profit	-	31	0	5	13	0	0	0	0	63
Operating Income	-10	17	-8	-3	4	-7	-8	-8	-7	56
EBITDA	-10	18	-8	-3	4	-7	-8	-7	-6	56
Interest Expense	-	0	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-9	18	-7	-2	5	-6	-7	-7	-6	56
Income Tax Expense	0	9	0	0	4	0	0	0	0	-
Net Income	-9	9	-7	-2	1	-6	-7	-7	-6	56
Net Profit Margin	0.00%	29.03%	-283.98%	-31.68%	7.45%	-415.84%	-314.40%	-584.09%	-369.06%	84.42%

Compugen Ltd Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	-	17	-	2	6	7	33	27	72
Gross Profit	0	-1	16	0	1	5	6	31	19	63
Operating Income	-32	-37	-23	-28	-31	-35	-35	-12	-14	31
EBITDA	-31	-35	-21	-27	-30	-34	-34	-12	-14	31
Interest Expense	0	0	0	1	1	0	0	0	0	-
Depreciation	-	1	1	0	0	0	0	0	0	0
Income Before Tax	-31	-37	-22	-28	-29	-34	-33	-9	-9	35
Income Tax Expense	0	0	-1	0	-2	-1	0	8	4	0
Net Income	-31	-37	-22	-27	-27	-32	-33	-18	-14	35
Net Profit Margin	-4425.00%	0.00%	-126.96%	0.00%	-1363.00%	-547.88%	-449.25%	-56.05%	-51.07%	48.57%

Compugen Ltd Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	9	-7	-2	1	-6	-7	-7	-6	56
Operating Cash Flow	-	-	-	-	-	-	-	-	31
Investing Cash Flow	-	-	-	-	-	-	-	-	29
Financing Cash Flow	-	-	-	-	-	-	-	-	10
Change in Cash	-	-	-	-	-	-	-	-	90

Compugen Ltd Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-37	-22	-27	-29	-34	-33	-18	-14	35
Operating Cash Flow	-30	-13	-27	-28	-23	-33	-35	49	31
Investing Cash Flow	46	-35	5	-82	6	37	35	-46	29
Financing Cash Flow	0	28	25	108	16	0	3	0	10
Change in Cash	15	-20	3	-2	0	2	2	3	72

Insights on Compugen Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, CGEN stock has moved up by 22.2%
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, CGEN has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, CGEN has outperformed top 5 stocks with highest market-cap in its industry

About Compugen Ltd

compugen is a leading drug discovery company focused on therapeutic proteins and monoclonal antibodies to address important unmet needs in the fields of immunology and oncology. the company utilizes a broad and continuously growing integrated infrastructure of proprietary scientific understandings and predictive platforms, algorithms, machine learning systems and other computational biology capabilities for the in silico (by computer) prediction and selection of product candidates, which are then advanced in its pipeline program. the company's business model includes collaborations covering the further development and commercialization of product candidates at various stages from its pipeline program and various forms of research and discovery agreements, in both cases providing compugen with potential milestone payments and royalties on product sales or other forms of revenue sharing. compugen’s wholly-owned u.s. subsidiary located in south san francisco is developing monoclonal antib

Organisation	Compugen Ltd
Headquarters	Azrieli Center, Holon, Israel, 5885849
Industry	Health Technology
CEO	Dr. Eran Ophir Ph.D.
E-voting on shares	Click here to vote

Key Management of Compugen Ltd

Name	Title
Dr. Zurit Levine Ph.D.	Senior Vice President of Business Development
Mr. Eran Ben Dor	General Counsel & Corporate Secretary
Rivka Schwartz	Vice President Research and Discovery
Dr. Sharon Kredo-Russo	Senior Vice President of Research & Discovery
Dr. Anat Cohen-Dayag Ph.D.	Executive Chair
Dr. Eran Ophir Ph.D.	CEO, President & Director
Dr. Pierre Ferre Ph.D.	Chief Operating Officer
Ms. Michelle Mahler M.D.	Chief Medical Officer
Mr. David Silberman CPA	Chief Financial Officer
Ms. Dorit Amitay	Vice President of Human Resources

FAQs

What is Compugen Ltd share price today?

Compugen Ltd share price today is $2.09 as on March 24, 2026 at 1:29 am IST at the close of the market. Compugen Ltd share today touched a day high of $2.15 and a low of $2.07.

What is the 52 week high and 52 week low for Compugen Ltd share?

Compugen Ltd share touched a 52 week high of $2.38 on January 16, 2026 and a 52 week low of $1.13 on April 9, 2025. Compugen Ltd stock price today i.e. March 24, 2026 at 1:29 am IST is closed at $2.09,which is 12.18% down from its 52 week high and 84.96% up from its 52 week low.

What is Compugen Ltd's market capitalisation today?

Compugen Ltd market capitalisation is $0.00T as on March 24, 2026 at 1:29 am IST.

How to invest in Compugen Ltd Stock (CGEN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Compugen Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Compugen Ltd Shares that will get you 0.7177 shares as per Compugen Ltd share price of $2.09 per share as on March 24, 2026 at 1:29 am IST.

What is the minimum amount required to buy Compugen Ltd Stock (CGEN) from India?

Indian investors can start investing in Compugen Ltd (CGEN) shares with as little as ₹94.058 or $1 (as of March 24, 2026 at 1:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹940.58 in Compugen Ltd stock (as per the Rupee-Dollar exchange rate as on March 24, 2026 at 1:41 am IST). Based on Compugen Ltd share’s latest price of $2.09 as on March 24, 2026 at 1:29 am IST, you will get 4.7847 shares of Compugen Ltd. Learn more about fractional shares .

What are the returns that Compugen Ltd has given to Indian investors in the last 5 years?

Compugen Ltd stock has given -75.58% share price returns and 29.13% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?